News
Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are ...
Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...
Tamar Braxton has announced a new brand partnership with Gilead Sciences. The music veteran will help educate and raise ...
4d
Amazon S3 on MSNNorthwell Health offers drug that aims to reduce transmission of HIV/AIDSNorthwell Health in Manhasset is offering an FDA-approved drug called Yeztugo, which is taken twice a year. Stephen Colbert's ...
A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...
Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
GSK expands Medicines Patent Pool deal to allow generic production of cabotegravir for HIV treatment
GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for ...
HIV pharma leaders are in Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results